Patient impressions of the impact of comorbidities on lung cancer screening benefits and harms: A qualitative analysis.
Patient impressions of the impact of comorbidities on lung cancer screening benefits and harms: A qualitative analysis.
复制标题
患者对合并症对肺癌筛查益处和危害的影响的印象:定性分析。
DOI:
10.1016/j.pec.2022.107590
复制
发表时间:
2023
影响因子:
3.5
通讯作者:
Schnur,Julie
中科院分区:
文献类型:
--
作者:
Kale,MinalS;Diefenbach,Michael;Masse,Sybil;Kee,Dustin;Schnur,Julie
ObjectiveTo learn about the beliefs and preferences of lung cancer screening (LCS) among patients undergoing LCS decision making. Specifically, we investigated how their comorbidity influences their interest in screening. The goal was to inform shared-decision making discussions around the role of comorbidities and LCS.MethodsWe recruited English-speaking LCS-eligible individuals with comorbidities from general medicine outpatient clinics at an academic medical center in New York City. The interviewers followed a semi-structured interview guide and all interviews were professionally transcribed. Study investigators independently conducted thematic analysis of de-identified transcripts; after coding, investigators discussed and agreed upon identified themes (Jacobs et al., 1999 [3]). This study was IRB-approved.ResultsWe achieved thematic saturation after 15 interviews. We identified the following themes: 1) Comorbidities were perceived as unrelated to LCS decision-making, 2) Lung cancer knowledge is valuable and worth any risks, 3) No matter what the guidelines or my providers say, the LCS decision is up to me.Conclusion/practice implicationsImplications of these findings are that conversations where providers recommend against LCS may likely require time, patient education, and appreciation of the patient perspective.